FDA Authorizes First-Of-Its-Kind Robotic Blood Draw Device

The FDA authorized Aletta, the first standalone robotic blood draw device that operates autonomously under phlebotomist supervision, aiming to address the U.S. phlebotomist shortage in adult outpatient settings.

This Wire brief sits within Fusion42's coverage of Medtech.